Virtu Financial’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,639
| Closed | -$241K | – | 1468 |
|
|
2024
Q1 | $241K | Buy |
+11,639
| New | +$241K | 0.02% | 703 |
|
|
2023
Q4 | – | Sell |
-15,480
| Closed | -$124K | – | 1688 |
|
|
2023
Q3 | $124K | Buy |
+15,480
| New | +$124K | 0.01% | 783 |
|
|
2021
Q2 | – | Sell |
-10,891
| Closed | -$111K | – | 1674 |
|
|
2021
Q1 | $111K | Buy |
+10,891
| New | +$111K | 0.01% | 1289 |
|
|
2020
Q4 | – | Sell |
-5,708
| Closed | -$30K | – | 1536 |
|
|
2020
Q3 | $30K | Buy |
+5,708
| New | +$30K | 0.01% | 886 |
|
|
2019
Q1 | – | Sell |
-1,655
| Closed | -$31K | – | 1517 |
|
|
2018
Q4 | $31K | Buy |
+1,655
| New | +$31K | ﹤0.01% | 1323 |
|
|
2018
Q2 | – | Sell |
-3,932
| Closed | -$48K | – | 2108 |
|
|
2018
Q1 | $48K | Buy |
+3,932
| New | +$48K | ﹤0.01% | 1724 |
|